Yardley, PA, United States of America

Ralph Adam Smith

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 12.2

ph-index = 3

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Ralph Adam Smith: Innovator in PD-L1 Binding Polypeptides

Introduction

Ralph Adam Smith is a notable inventor based in Yardley, PA (US). He holds a total of 4 patents that contribute significantly to the field of diagnostics and imaging. His work primarily focuses on PD-L1 binding polypeptides, which have important applications in medical imaging.

Latest Patents

Among his latest patents are innovative developments in PD-L1 binding polypeptides for imaging. These patents provide novel Fn3 domains that specifically bind to PD-L1, along with imaging agents designed for diagnostic purposes. Another significant patent involves PET imaging with PD-L1 binding polypeptides, further enhancing the capabilities of diagnostic imaging in medical applications.

Career Highlights

Ralph Adam Smith is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research and innovations. His contributions to the field have been recognized for their potential impact on diagnostics and treatment strategies.

Collaborations

Some of his notable coworkers include Paul E Morin and David J Donnelly, who collaborate with him on various projects related to his patents and research initiatives.

Conclusion

Ralph Adam Smith's work in PD-L1 binding polypeptides showcases his commitment to innovation in the field of medical diagnostics. His patents reflect a significant advancement in imaging technology, which may lead to improved diagnostic capabilities in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…